Wakamoto Pharmaceutical Co.,Ltd.
4512
Rank in Stocks
#21763
Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in... Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in the production and distribution of both prescription and over-the-counter pharmaceuticals across the country. Their diverse offerings include Strong Wakamoto, a widely recognized gastrointestinal aid formulated to enhance digestion, regulate intestinal health, and supplement nutrition. Additionally, the company provides AVANTBISE oral tablets, a dietary supplement designed to rebalance the oral microbiome, as well as various medicated toothpastes. Founded in 1929, the enterprise was initially known as Society for Nutrition and Raising Children Co., Ltd. before formally changing its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943.
Share Price
$1.82
Last synced: 2026-11-10
Market Cap
$63.05M
Change (1 day)
3.61%
Change (1 year)
-0.75%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Wakamoto Pharmaceutical Co.,Ltd. (4512)
Category
Healthcare
EPS for Wakamoto Pharmaceutical Co.,Ltd. (4512)
EPS as of June 2026 TTM: $0.06
According to Wakamoto Pharmaceutical Co.,Ltd.'s latest financial reports, its current EPS (TTM) is $0.06. At the end of 2025 the company had an EPS of $0.01, a decrease compared to its 2024 EPS of $0.02.
EPS history for Wakamoto Pharmaceutical Co.,Ltd. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.06 | 524.00% |
| 2025 | $0.01 | -40.10% |
| 2024 | $0.02 | -31.00% |
| 2023 | $0.03 | -46.81% |
| 2022 | $0.06 | -136.02% |
| 2021 | $-0.16 | -64.72% |
| 2020 | $-0.44 | 844.47% |
| 2019 | $-0.05 | -237.43% |
| 2018 | $0.03 | 39.59% |
| 2017 | $0.02 | 371.15% |
| 2016 | $0.01 | -74.00% |
| 2015 | $0.02 | -91.51% |
| 2014 | $0.24 | 321.47% |
| 2013 | $0.06 | -172.69% |
| 2012 | $-0.08 | -48.18% |
| 2011 | $-0.15 | -1,082.78% |
| 2010 | $0.02 | -85.44% |
| 2009 | $0.10 | -13.80% |
| 2008 | $0.12 | -1.96% |
| 2007 | $0.12 | 15.21% |
| 2006 | $0.11 | -15.07% |
| 2005 | $0.13 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 10,318.91% |
DE
|
|
| $6.08 | 9,639.74% |
DE
|
|
| $1.55 | 2,384.94% |
JP
|
|
| $3.66 | 5,765.38% |
CH
|
|
| $0.45 | 621.15% |
IL
|
Questions about Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS)
What is Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS)?
Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) over the last twelve months is $0.06, as of Jun 2026.
What was Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) in 2025?
In 2025, Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) was $0.01, 50.00% less than in 2024 ($0.02).
How has Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) was highest in 2022 ($0.06) and lowest in 2020 ($-0.44).
How does Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) compare with similar companies?
Wakamoto Pharmaceutical Co.,Ltd.'s earnings per share (EPS) ($0.06) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.